Your browser doesn't support javascript.
loading
In vitro activity of the novel oral antimicrobial SMT-571, with a new mechanism of action, against MDR and XDR Neisseria gonorrhoeae: future treatment option for gonorrhoea?
Jacobsson, Susanne; Mason, Clive; Khan, Nawaz; Meo, Paul; Unemo, Magnus.
Afiliación
  • Jacobsson S; WHO Collaborating Centre for Gonorrhoea and Other Sexually Transmitted Infections, National Reference Laboratory for Sexually Transmitted Infections, Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Mason C; Summit Therapeutics, Merrifield Centre, Rosemary Lane, Cambridge, UK.
  • Khan N; Summit Therapeutics, Merrifield Centre, Rosemary Lane, Cambridge, UK.
  • Meo P; Summit Therapeutics, Merrifield Centre, Rosemary Lane, Cambridge, UK.
  • Unemo M; WHO Collaborating Centre for Gonorrhoea and Other Sexually Transmitted Infections, National Reference Laboratory for Sexually Transmitted Infections, Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
J Antimicrob Chemother ; 74(6): 1591-1594, 2019 06 01.
Article en En | MEDLINE | ID: mdl-30778550
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Farmacorresistencia Bacteriana / Antibacterianos / Neisseria gonorrhoeae Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Antimicrob Chemother Año: 2019 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Farmacorresistencia Bacteriana / Antibacterianos / Neisseria gonorrhoeae Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Antimicrob Chemother Año: 2019 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Reino Unido